Andrew
Today Andrew begins a new medication, a MEK inhibitor called trametinib, to hopefully reduce the tumor. It is not a chemotherapy, so on a good note, he will not have the typical chemotherapy side effects. It does, however, have its own long list of possible side effects, some major, but
Read more